Alexandria Venture Investments Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 304
  • Portfolio
  • 143
  • Exits
  • 93
Exits

Alexandria Venture Investments General Information

Description

Founded in 1996, Alexandria Venture Investments is a venture capital firm based in Pasadena, California. The firm prefers to invest in seed-stage, early-stage, and growth-stage companies. The firm also seeks to invest in healthcare, information technology, materials, and resources sectors.

Contact Information

Year Founded
1996
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 26 North Euclid Avenue
  • Pasadena, CA 91101
  • United States
+1 (626) 000-0000

Alexandria Venture Investments Investments (304)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Creyon Bio 08-Mar-2022 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials
0000000 08-Mar-2022 00000 00000 0000 Drug Discovery Generating Revenue
00000000 15-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue
000000 00000000000 15-Feb-2022 00000 00000 0000 Discovery Tools (Healthcare) Generating Revenue
000000 00000000000 09-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue
00000 000 05-Jan-2022 00000 00000 00000 Drug Discovery Generating Revenue
00000 000000000 21-Dec-2021 00000 00000 0000 Drug Discovery Product Development
000000000 14-Dec-2021 00000 00000 000.00 Other Agriculture Generating Revenue/Not Profitable
NextVivo 09-Dec-2021 Seed Round 00.00 Drug Discovery Startup
Fountain Therapeutics 18-Nov-2021 Early Stage VC 0000 Drug Discovery Generating Revenue
You’re viewing 10 of 304 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alexandria Venture Investments Exits (93)

Company Name Exit Date Exit Type Exit Size
GreenLight Biosciences 04-Feb-2022 Reverse Merger 00000
00000 00000 07-Jan-2022 000 0000
0000 17-Dec-2021 0000000 000000 00.00
0000000 0000000000 04-Nov-2021 000 00000
0000 00000000000 02-Nov-2021 000 000.00
0000000000 0000000 07-Oct-2021 000000000000000000
000000 0000 30-Sep-2021 0000000 000000 00000
000000 00000000000 24-Sep-2021 000000000000000000 00000
DiCE Molecules 15-Sep-2021 IPO 00000
eFFECTOR Therapeutics 26-Aug-2021 Reverse Merger 00000
You’re viewing 10 of 93 exits. Get the full list »

Alexandria Venture Investments Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Alexandria Venture Investments Team (9)

Name Title Deals Funds Boards Office
Jenna Foger Senior Vice President, Science & Technology 0 0 Pasadena, CA
Monica Beam Ph.D Senior Vice President, Science & Technology 0 0 Pasadena, CA
Aaron Jacobson Senior Vice President, Venture Counsel Pasadena, CA
Jeff Stevens Vice President, Science & Technology 0 0 Pasadena, CA
Dean Shigenaga President & Chief Financial Officer, Alexandria Real Estate Equities Pasadena, CA
You’re viewing 5 of 9 team members. Get the full list »

Alexandria Venture Investments Co-Investors (620)

Name With Exits Lead Partner Series Industry
ARCH Venture Partners 23 0 0 Series chart Industry bar
Casdin Capital 00 0 0 Series chart Industry bar
GV 00 0 0 Series chart Industry bar
RA Capital Management 00 0 0 Series chart Industry bar
Pfizer Ventures 00 0 00 Series chart Industry bar
You’re viewing 5 of 620 co-investors. Get the full list »